Home » Research » Resources » Biospecimen Bank
SARC has banked human biospecimens from sarcoma patients participating in our clinical trials into a single biorepository. The SARC Biospecimen Bank consists of thousands of specimens that are well-annotated and linked with patient clinical, treatment, and outcome data. This collection is designed to help qualified sarcoma investigators or organizations gain access to specimens to explore biomarkers, identify therapeutic targets, or make discoveries.
High quality biospecimens available from various procedures and clinical laboratory assessments include:
NOTE: Specimens are only available from trials that are closed (e.g., from trials that have completed analyses of endpoints) and the results published, although there may be rare exceptions.
A current SARC Biospecimens Bank inventory list is available. Please contact us.
To be considered eligible to access the SARC Biospecimen Bank, investigators must:
We are especially interested in developing technologies that may be tested in a prospective multi-institutional group setting.
Eligible organizations may include:
Investigators should budget for all aspects of proposed research, including technical support, supplies and equipment, specimen preparation and shipping, as well as investigator and research staff salaries.
Limited SARC funding may be available, but outside funding is suggested. If funding has been secured, documentation must be provided with the application (award letter required). If you are applying for grant support, SARC will provide a letter of support including commitment to samples if funding is secured. SARC will partner with investigators to explore funding options.
In general, specimens are released only after and if the protocol-specified correlatives and primary endpoint(s) for the trial have been met.
Reviewers consider each application independently according to the following criteria:
Applications may be submitted at any time.
Request samples by completing our Biospecimen Access Application Form and submitting the form to SARC@sarctrials.org.
© 2022 Sarcoma Alliance For Research Through
Sign up for our monthly SARC newsletter and updates on clinical trials.